Volume 05, Issue 01

 

ارسال های اخیر

  • The Effect of Cyclodextrin on the Action of Drugs and Their Release in the Body 

    Salma, Saad؛ Jamal, Rafat (Iranian-Australian Community of Science http://irausci.ir, 2021-03-01)
    In some cases, in order to overcome the immune mechanisms or faster drug absorption, various routes are considered for drug administration. Regarding the physicochemical properties of many drugs, it is possible that they ...

  • Study of Nano-Dual Organic-Hydroxide Drug Delivery System for Anticancer Drugs 

    Rad, Saeid؛ Yazdi, Esmaeil (Iranian-Australian Community of Science http://irausci.ir, 2021-03-01)
    Mg – Al layered double hydroxide nanoparticles were synthesized by co-precipitation method and anticancerous drug Cabozantinib (CBZ) was intercalated into it by in-situ ion exchange. The LDH –CBZ nanohybrid produced stable ...

  • Medical nanotechnology and the development of methods for the diagnosis and treatment of cancer 

    Safari, Sobhan؛ Saraeian, Elmira (Iranian-Australian Community of Science http://irausci.ir, 2021-03-01)
    Nanotechnology is the design and assembly of submicroscopic devices called nanoparticles, which are 1–100 nm in diameter. The application of nanotechnology for the diagnosis and treatment of human disease has been a growing ...

  • DFT Study of Boron-Fullerene Carrier for Delivery of Anticancer Drugs 

    Meor, Mustafa؛ Manap, Dave (Iranian-Australian Community of Science http://irausci.ir, 2021-03-01)
    The structures of boron-doped fullerene B-C59 (1) as a drug delivery system, two derivatives of cyclophosphamide anticancer prodrug (2 and 3) as well as their covalently bonded structures 4 and 5 were optimized by DFT ...

  • Determination of Cytotoxicity of Anticancer Drug Doxorubicin and its Side Effects 

    Al Sabah, Ahmed؛ Maghdoon, Rashid (Iranian-Australian Community of Science http://irausci.ir, 2021-03-01)
    The clinical use of the anticancer drug doxorubicin (DOX) is limited by strong side effects and phenomena of cell resistance. Drug targeting by binding DOX to nanoparticles could overcome these limitations. We recently ...